Deoxyguanosine is a TLR7 agonist

Deoxyguanosine is a TLR7 agonist

Toll-like receptor 7 (TLR7) is an innate immune sensor for single-strand RNA (ssRNA). Recent structural analysis revealed that TLR7 has an additional binding site for nucleosides such as guanosine and is activated when both guanosine and ssRNA bind. The nucleoside binding site also accommodates imid...

Descripció completa

Dades bibliogràfiques
Autors principals:	Davenne, T, Bridgeman, A, Rigby, R, Rehwinkel, J
Format:	Journal article
Idioma:	English
Publicat:	Wiley 2019

Ítems similars

Comparison of human B cell activation by TLR7 and TLR9 agonists
per: Neys Lori, et al.
Publicat: (2008-07-01)

The role of TLR7 agonists in modulating COVID-19 severity in subjects with loss-of-function TLR7 variants
per: Shaik Mohammad Naushad, et al.
Publicat: (2023-08-01)

Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer.
per: Nikunj M Shukla, et al.
Publicat: (2012-01-01)

Molecular dynamics simulations reveal the selectivity mechanism of structurally similar agonists to TLR7 and TLR8.
per: Xiaoyu Wang, et al.
Publicat: (2022-01-01)

The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
per: Li Zhang, et al.
Publicat: (2015-01-01)

PNP inhibitors selectively kill cancer cells lacking SAMHD1
per: Tamara Davenne, et al.
Publicat: (2020-11-01)

BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant
per: Deepender Kaushik, et al.
Publicat: (2020-08-01)

Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists
per: Vasilakos John P, et al.
Publicat: (2007-10-01)

Alum and a TLR7 agonist combined with built-in TLR4 and 5 agonists synergistically enhance immune responses against HPV RG1 epitope
per: Maryam Mashhadi Abolghasem Shirazi, et al.
Publicat: (2023-10-01)

Varicella-Zoster virus ORF9 Is an antagonist of the DNA sensor cGAS
per: Hertzog, J, et al.
Publicat: (2020)

Determining 8-oxo-2’-deoxyguanosine/2’-deoxyguanosine ratio in DNA by reverse phase HPLC combined with amperometric detection
per: D. S. Esipov, et al.
Publicat: (2010-06-01)

Synthesis of 8-oxo-7,8-dihydro-2′-deoxyguanosine from 2′-deoxyguanosine using Cu(II)/H2O2/ascorbate: A new strategy for an improved yield
per: Patrícia S. Peres, et al.
Publicat: (2016-06-01)

Genomic 8-oxo-7,8-dihydro-2&#39;-deoxyguanosine Quantification
per: Antonio Sarno
Publicat: (2013-09-01)

Interferon induction held captive in tumor cells
per: Bridgeman, A, et al.
Publicat: (2021)

Innate immune receptors in human airway smooth muscle cells: activation by TLR1/2, TLR3, TLR4, TLR7 and NOD1 agonists.
per: Anne Månsson Kvarnhammar, et al.
Publicat: (2013-01-01)

NOD2 Agonist Promotes the Production of Inflammatory Cytokines in VSMC in Synergy with TLR2 and TLR4 Agonists
per: Jinghua Sun, et al.
Publicat: (2012-01-01)

Electrophilic Substitution at C(7) of a Protected 7-Deaza-2’-deoxyguanosine – The 2’-Deoxyribonucleoside Parent Analogue of Queuosine #
per: Helmut Rosemeyer, et al.
Publicat: (2007-04-01)

Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
per: Aashna Jassal, et al.
Publicat: (2024-11-01)

ProLonged Liposomal Delivery of TLR7/8 Agonist for Enhanced Cancer Vaccine
per: Sehui Kim, et al.
Publicat: (2023-09-01)

A Therapeutic Whole-Tumor-Cell Vaccine Covalently Conjugated with a TLR7 Agonist
per: Huju Chi, et al.
Publicat: (2022-06-01)

8-Oxo-7,8-Dihydro-2′-Deoxyguanosine (8-oxodG) and 8-Hydroxy-2′-Deoxyguanosine (8-OHdG) as a Potential Biomarker for Gestational Diabetes Mellitus (GDM) Development
per: Sandra K. Urbaniak, et al.
Publicat: (2020-01-01)

Varicella‐Zoster virus ORF9 is an antagonist of the DNA sensor cGAS
per: Hertzog, J, et al.
Publicat: (2022)

Viruses transfer the antiviral second messenger cGAMP between cells
per: Bridgeman, A, et al.
Publicat: (2015)

Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist
per: Craig L Slingluff, et al.
Publicat: (2021-05-01)

A TLR7/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models
per: Bethany Crouse, et al.
Publicat: (2023-07-01)

T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
per: Verena Turco, et al.
Publicat: (2023-02-01)

Biotinylation of Deoxyguanosine at the Abasic Site in Double-Stranded Oligodeoxynucleotides
per: Chun Wu
Publicat: (2016-01-01)

Mitochondrial deoxyguanosine kinase is required for female fertility in mice
per: Gao Yake, et al.
Publicat: (2024-02-01)

1161 Development of TLR7- and STING-conjugatable agonists for immunostimulatory ADC-based cancer therapies
per: Fabienne Vernejoul, et al.
Publicat: (2023-11-01)

8-Oxo-2’-deoxyguanosine – biomarker of the oxidative stress
per: T. S. Nevredimova, et al.
Publicat: (2014-10-01)

Sequence-Dependent Variation in the Reactivity of 8-Oxo-7,8-dihydro-2′-deoxyguanosine toward Oxidation
per: Lim, Kok Seong, et al.
Publicat: (2014)

Formulated Phospholipids as Non-Canonical TLR4 Agonists
per: Hong Liang, et al.
Publicat: (2022-11-01)

The mechanism of decomposition of N-methyl-N-nitrosourea (MNU) in water and a study of its reactions with 2'-deoxyguanosine, 2'-deoxyguanosine 5'-monophosphate and d(GTGCAC)
per: Golding, B, et al.
Publicat: (1997)

Deoxyguanosine kinase deficiency: natural history and liver transplant outcome
per: Manzoni, E, et al.
Publicat: (2024)

Employing Drug Delivery Strategies to Overcome Challenges Using TLR7/8 Agonists for Cancer Immunotherapy
per: Varshney, Dhruv, et al.
Publicat: (2022)

Employing Drug Delivery Strategies to Overcome Challenges Using TLR7/8 Agonists for Cancer Immunotherapy
per: Varshney, Dhruv, et al.
Publicat: (2021)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of a TLR7 agonist prodrug RO6870868 in healthy volunteers
per: Joseph F. Grippo, et al.
Publicat: (2021-07-01)

Identifying the Tautomeric Form of a Deoxyguanosine-Estrogen Quinone Intermediate
per: Douglas E. Stack
Publicat: (2015-09-01)

Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists
per: Linda K. Curtiss, et al.
Publicat: (2012-10-01)

The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer
per: Katherine A. Michaelis, et al.
Publicat: (2019-10-01)